HIGHLIGHTS
- who: Hao Liao from the Methods: Blood samples from , ABC patients who underwent first-line standard treatment in Peking University Cancer Hospital and Institute, Fucheng Rd, Beijing, China have published the research work: Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients, in the Journal: (JOURNAL)
- what: Registered January 3rd 2019 https://u200bcliniu200bcaltru200bials.u200bgov/u200bct2/u200bshow/u200b NCT03u200b792529. u2020 contributed equally to this work Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Breast Oncology Peking University Full list of author information is available . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.